This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The State University of New York. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: John Fonda Crary: Innovator in Nervous System Disorders and Cancer Research
Introduction
John Fonda Crary is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in understanding the role of atypical protein kinase C isoforms in disorders of the nervous system and cancer. His work has implications for diagnosing and treating conditions such as Alzheimer's disease and neuroblastoma.
Latest Patents
John Fonda Crary holds a patent titled "Atypical protein kinase C isoforms in disorders of the nervous system and cancer." This invention establishes a crucial link between altered aPKC function and various nervous system disorders and cancers. The patent outlines methods for using aPKC in diagnosis, drug screening, and gene therapy, providing valuable tools for addressing these serious health issues. He has 1 patent to his name.
Career Highlights
Crary is affiliated with The State University of New York, where he continues to advance research in his field. His academic and professional journey reflects a commitment to understanding complex biological processes and their implications for human health.
Collaborations
Throughout his career, John Fonda Crary has collaborated with esteemed colleagues, including Todd Charlton Sacktor and Alejandro Ivan Hernandez. These partnerships have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
John Fonda Crary's innovative work in the realm of nervous system disorders and cancer research highlights the importance of scientific inquiry in addressing critical health challenges. His contributions continue to pave the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
